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Background
Human regulatory T cells (T reg) are classically defined as
CD4+ CD25hi Foxp3+. There is increasing evidence that T
cells may be subject to regulation via the conversion of
proinflammatory ATP to anti-inflammatory adenosine.
Methotrexate, the standard therapy for children with JIA,
is proposed to work via this mechanism. CD39 belongs to
a family of ectoenzymes that convert ATP into an adenos-
ine precursor. ATPase activity may therefore represent an
important regulatory mechanism in JIA.
Materials and methods
Mononuclear cells from peripheral blood (PBMC) and
synovial fluid (SFMC) of patients with JIA were analysed
in parallel with PBMC from healthy controls. Samples
were analysed by 5-colour flow cytometry for expression
of Foxp3, CD25 and CD39. FACS sorted cells were assayed
for ATPase activity.
Results
CD39 expression was demonstrated on a variety of mono-
nuclear cells in both controls and JIA patients. Increased
expression of CD39 was seen on SFMC. Mononuclear
cells expressing CD39 showed rapid ATPase activity in
vitro. We characterise a proportion of CD39+ T cells with
a memory phenotype, express Foxp3 and have regulatory
function.
Conclusion
ATPase activity may represent a novel mechanism by
which regulation may occur in JIA. CD39+ CD4 cells are
enriched in the joint in JIA. CD4+ T cells which express
both CD39 and Foxp3 may represent a population with
the capability to regulate via multiple mechanisms and
therefore be more potent suppressors.
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